Drug profile · INN
methohexital sodium
METHOHEXITAL SODIUM
methohexital sodium (METHOHEXITAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: injection. Current US regulatory status: approved.
Drug details — methohexital sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
methohexital sodium (METHOHEXITAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methohexital sodium?
methohexital sodium (METHOHEXITAL SODIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for methohexital sodium?
METHOHEXITAL SODIUM is a marketed brand name for methohexital sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methohexital sodium?
methohexital sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.